133 related articles for article (PubMed ID: 17429429)
21. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
[TBL] [Abstract][Full Text] [Related]
22. Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
Vezzoli P; Novara F; Fanoni D; Gambini D; Balice Y; Venegoni L; Paulli M; Crosti C; Berti E
Leuk Lymphoma; 2012 Oct; 53(10):1978-87. PubMed ID: 21879810
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.
Dabrowska MJ; Ejegod D; Lassen LB; Johnsen HE; Wabl M; Pedersen FS; Dybkær K
Leuk Res; 2013 Oct; 37(10):1383-90. PubMed ID: 23896059
[TBL] [Abstract][Full Text] [Related]
24. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
25. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
26. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
[TBL] [Abstract][Full Text] [Related]
28. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
29. Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats.
van den Brandt J; Kwon SH; McPherson KG; Petrovic S; Zettl A; Müller-Hermelink HK; Reichardt HM
Eur J Immunol; 2006 Aug; 36(8):2223-34. PubMed ID: 16838279
[TBL] [Abstract][Full Text] [Related]
30. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
[TBL] [Abstract][Full Text] [Related]
31. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.
Dolcetti R; Giardini R; Doglioni C; Cariati R; Pomponi F; D'Orazi C; Rao S; Lazarovits AI; Butcher EC; Boiocchi M
Am J Pathol; 1997 May; 150(5):1595-605. PubMed ID: 9137086
[TBL] [Abstract][Full Text] [Related]
32. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
33. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
[TBL] [Abstract][Full Text] [Related]
34. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
35. FoxN1-dependent thymic epithelial cells promote T-cell leukemia development.
Ghezzo MN; Fernandes MT; Pacheco-Leyva I; Rodrigues PM; Machado RS; Araújo MAS; Kalathur RK; Futschik ME; Alves NL; Dos Santos NR
Carcinogenesis; 2018 Dec; 39(12):1463-1476. PubMed ID: 30256907
[TBL] [Abstract][Full Text] [Related]
36. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
Andersson A; Edén P; Lindgren D; Nilsson J; Lassen C; Heldrup J; Fontes M; Borg A; Mitelman F; Johansson B; Höglund M; Fioretos T
Leukemia; 2005 Jun; 19(6):1042-50. PubMed ID: 15843827
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
40. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia].
Chiali-Gritti C
Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]